pharmaceutical facility design Archives

Skip to content Skip to sidebar Skip to footer

Pharmaco Global blog banner titled Design for Export, comparing EU GMP, WHO GMP, and USFDA cGMP compliance pathways for pharmaceutical facility design. The dark navy visual shows a gowned scientist in a cleanroom operating a stainless steel processing vessel, alongside a filling line of capped vials, a container ship at a port, and a world map with connected export routes. Icons highlight three pillars: Compliance, Facility Design, and Export. The headline advises pharmaceutical manufacturers to choose the right GMP pathway before facility decisions lock in. A closing tagline reads: build compliant facilities and unlock global markets across regulated regions.

EU GMP vs WHO GMP vs USFDA cGMP: A Guide for Pharmaceutical Exporters

BlogJuly 30, 2026219Views 0Likes 0Comments

Choosing the wrong GMP pathway can delay facility approvals, increase project costs, and restrict access to target export markets. While EU GMP, WHO GMP, and USFDA cGMP share similar quality principles, they differ in regulatory authority, inspection requirements, compliance evidence, and market application. This guide compares the three frameworks, explains what their certificates and inspections…